Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Clostridium difficile infections in Finland, 2008-2015: trends, diagnostics and ribotypes.

Mentula S, Kotila SM, Lyytikäinen O, Ibrahem S, Ollgren J, Virolainen A.

Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1939-1945. doi: 10.1007/s10096-017-3017-5. Epub 2017 May 30.

PMID:
28555402
2.

Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.

Pituch H, Obuch-Woszczatyński P, Lachowicz D, Wultańska D, Karpiński P, Młynarczyk G, van Dorp SM, Kuijper EJ; Polish Clostridium difficile Study Group.

Euro Surveill. 2015;20(38). doi: 10.2807/1560-7917.ES.2015.20.38.30025.

3.

Reduction in Clostridium difficile infections in Finland, 2008-2010.

Kanerva M, Mentula S, Virolainen-Julkunen A, Kärki T, Möttönen T, Lyytikäinen O; Hospital Infection Surveillance Team.

J Hosp Infect. 2013 Feb;83(2):127-31. doi: 10.1016/j.jhin.2012.09.021. Epub 2012 Nov 30.

PMID:
23201398
4.
5.

Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.

Humphries RM, Uslan DZ, Rubin Z.

J Clin Microbiol. 2013 Mar;51(3):869-73. doi: 10.1128/JCM.02970-12. Epub 2012 Dec 26.

6.

Regional differences in Clostridium difficile infections in relation to fluoroquinolone and proton pump inhibitor use, Finland, 2008-2011.

Kanerva M, Ollgren J, Voipio T, Mentula S, Lyytikäinen O.

Infect Dis (Lond). 2015 Aug;47(8):530-5. doi: 10.3109/23744235.2015.1026933. Epub 2015 Apr 2.

PMID:
25832317
7.

Clostridium difficile PCR ribotypes 001 and 176 - the common denominator of C. difficile infection epidemiology in the Czech Republic, 2014.

Krutova M, Matejkova J, Kuijper EJ, Drevinek P, Nyc O; Czech Clostridium difficile study group.

Euro Surveill. 2016 Jul 21;21(29). doi: 10.2807/1560-7917.ES.2016.21.29.30296.

8.

Occurrence of Clostridium difficile infections in Serbia and high proportion of PCR ribotype 027 strains in two hospitals in Belgrade.

Jovanović M, Drakulović M, Tošić T, Stošović R, Jovanović S.

Anaerobe. 2018 Jun;51:64-67. doi: 10.1016/j.anaerobe.2018.04.005. Epub 2018 Apr 5.

PMID:
29627510
9.

Diagnostic testing for Clostridium difficile in Italian microbiological laboratories.

Spigaglia P, Barbanti F, Morandi M, Moro ML, Mastrantonio P.

Anaerobe. 2016 Feb;37:29-33. doi: 10.1016/j.anaerobe.2015.11.002. Epub 2015 Nov 7.

PMID:
26555737
10.

Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014.

van Dorp SM, Notermans DW, Alblas J, Gastmeier P, Mentula S, Nagy E, Spigaglia P, Ivanova K, Fitzpatrick F, Barbut F, Morris T, Wilcox MH, Kinross P, Suetens C, Kuijper EJ; European Clostridium difficile Infection Surveillance Network (ECDIS-Net) project on behalf of all participants.

Euro Surveill. 2016 Jul 21;21(29). doi: 10.2807/1560-7917.ES.2016.21.29.30292.

11.

Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.

Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A, Cairns M, Curran MD, Dodgson KJ, Green SM, Hardy KJ, Hawkey PM, Magee JG, Sails AD, Wren MW.

Clin Infect Dis. 2012 Oct;55(8):1056-63. Epub 2012 Jul 11.

PMID:
22784871
12.

Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013.

Fawley WN, Davies KA, Morris T, Parnell P, Howe R, Wilcox MH; Clostridium difficile Ribotyping Network (CDRN) Working Group.

Euro Surveill. 2016 Jul 21;21(29). doi: 10.2807/1560-7917.ES.2016.21.29.30295.

13.

Incidence, case fatality and genotypes causing Clostridium difficile infections, Finland, 2008.

Kotila SM, Virolainen A, Snellman M, Ibrahem S, Jalava J, Lyytikäinen O.

Clin Microbiol Infect. 2011 Jun;17(6):888-93. doi: 10.1111/j.1469-0691.2010.03384.x. Epub 2010 Nov 10.

14.

Diagnostic trends in Clostridium difficile detection in Finnish microbiology laboratories.

Könönen E, Rasinperä M, Virolainen A, Mentula S, Lyytikäinen O.

Anaerobe. 2009 Dec;15(6):261-5. doi: 10.1016/j.anaerobe.2009.06.008. Epub 2009 Jul 8.

PMID:
19591954
15.

Molecular characteristics of Clostridium difficile strains from patients with a first recurrence more than 8 weeks after the primary infection.

Chen Y, Rashid MU, Huang H, Fang H, Nord CE, Wang M, Weintraub A.

J Microbiol Immunol Infect. 2017 Aug;50(4):532-536. doi: 10.1016/j.jmii.2015.10.017. Epub 2015 Dec 1.

16.

Polymerase chain reaction ribotyping of Clostridium difficile isolates in Qatar: a hospital-based study.

Al-Thani AA, Hamdi WS, Al-Ansari NA, Doiphode SH, Wilson GJ.

BMC Infect Dis. 2014 Sep 15;14:502. doi: 10.1186/1471-2334-14-502. Erratum in: BMC Infect Dis. 2015;15:173. Wilson, Godwin Justus [added].

17.

Clinical and laboratory features of the most common Clostridium difficile ribotypes isolated in Belgium.

Neely F, Lambert ML, Van Broeck J, Delmée M.

J Hosp Infect. 2017 Apr;95(4):394-399. doi: 10.1016/j.jhin.2016.12.011. Epub 2016 Dec 18.

PMID:
28153559
18.

Optimizing the Laboratory Diagnosis of Clostridium difficile Infection.

Gilligan PH.

Clin Lab Med. 2015 Jun;35(2):299-312. doi: 10.1016/j.cll.2015.02.003. Epub 2015 Mar 18. Review.

PMID:
26004644
19.

What do we know about the diagnostics, treatment and epidemiology of Clostridioides (Clostridium) difficile infection in Europe?

Nagy E.

J Infect Chemother. 2018 Mar;24(3):164-170. doi: 10.1016/j.jiac.2017.12.003. Epub 2017 Dec 27. Review.

PMID:
29289484
20.

Use of modified PCR ribotyping for direct detection of Clostridium difficile ribotypes in stool samples.

Janezic S, Strumbelj I, Rupnik M.

J Clin Microbiol. 2011 Aug;49(8):3024-5. doi: 10.1128/JCM.01013-11. Epub 2011 Jun 1.

Supplemental Content

Support Center